tirzepatide mounjaro news - Search News

FDA, Mounjaro and Zepbound

Hosted on MSN · 2h

LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List

The FDA removed Eli Lilly’s LLY tirzepatide injection products from the drug shortage list after determining that Lilly’s supply is currently meeting or exceeding demand and will continue to do so in the future.

USA Today · 20h

FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for these medications.

FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period

The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put a stop to companies making cheaper copies.

MedPage Today15h

FDA Says Compounded Tirzepatide Must Exit the Market

Approved in 2022 for type 2 diabetes and in 2023 for chronic weight management along with diet and exercise, tirzepatide is ...

1d

FDA keeps Mounjaro off shortage list after reevaluation

The Food and Drug Administration (FDA) has reaffirmed that Mounjaro and Zepbound are no longer in shortage following a ...

20hon MSN

FDA says tirzepatide shortage is over after taking a second look

The FDA said Thursday it’s standing by its earlier decision that the shortage of tirzepatide — the active ingredient in Eli ...

FiercePharma23h

FDA reaffirms decision to erase Eli Lilly's tirzepatide from shortage list, halting future flow of knockoffs

The FDA has doubled down on its decision to remove Eli Lilly’s tirzepatide from its list of products that are in shortage. | ...

1d

FDA says shortage of GLP-1 tirzepatide is over

The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results